Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease.

Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmermann EM, Sartor RB, Lund PK.

Am J Physiol Gastrointest Liver Physiol. 2000 Dec;279(6):G1307-22.

2.

Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease.

Zimmermann EM, Li L, Hou YT, Mohapatra NK, Pucilowska JB.

Am J Physiol Gastrointest Liver Physiol. 2001 May;280(5):G1022-9.

3.

TGF-beta1 and IGF-1 and anastomotic recurrence of Crohn's disease after ileo-colonic resection.

Scarpa M, Bortolami M, Morgan SL, Kotsafti A, Ruffolo C, D'Incà R, Bertin E, Polese L, D'Amico DF, Sturniolo GC, Angriman I.

J Gastrointest Surg. 2008 Nov;12(11):1981-90. doi: 10.1007/s11605-008-0641-5. Epub 2008 Aug 13.

PMID:
18704594
4.

Collagen content and types in the intestinal strictures of Crohn's disease.

Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, Gay R.

Gastroenterology. 1988 Feb;94(2):257-65.

PMID:
3335305
5.

Altered expression of type I insulin-like growth factor receptor in Crohn's disease.

El Yafi F, Winkler R, Delvenne P, Boussif N, Belaiche J, Louis E.

Clin Exp Immunol. 2005 Mar;139(3):526-33.

6.
7.

IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts.

Simmons JG, Pucilowska JB, Keku TO, Lund PK.

Am J Physiol Gastrointest Liver Physiol. 2002 Sep;283(3):G809-18.

8.

Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions.

Williams KL, Fuller CR, Fagin J, Lund PK.

Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G875-85.

9.

Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis.

Zimmermann EM, Sartor RB, McCall RD, Pardo M, Bender D, Lund PK.

Gastroenterology. 1993 Aug;105(2):399-409.

PMID:
8335195
10.

Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats.

Zeeh JM, Riley NE, Hoffmann P, Reinshagen M, Goebell H, Gerken G.

Eur J Gastroenterol Hepatol. 2001 Jul;13(7):851-8.

PMID:
11474316
11.

A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC.

Stucchi A, Reed K, O'Brien M, Cerda S, Andrews C, Gower A, Bushell K, Amar S, Leeman S, Becker J.

Inflamm Bowel Dis. 2006 Jul;12(7):581-7.

PMID:
16804395
12.

Beta2 integrin/ICAM expression in Crohn's disease.

Bernstein CN, Sargent M, Gallatin WM.

Clin Immunol Immunopathol. 1998 Feb;86(2):147-60.

PMID:
9473377
13.
14.

VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.

Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K.

Am J Gastroenterol. 2001 Mar;96(3):822-8.

PMID:
11280558
15.

Intestinal subepithelial myofibroblasts in inflammatory bowel diseases.

Andoh A, Fujino S, Okuno T, Fujiyama Y, Bamba T.

J Gastroenterol. 2002 Nov;37 Suppl 14:33-7.

PMID:
12572863
16.

Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts.

McKaig BC, Hughes K, Tighe PJ, Mahida YR.

Am J Physiol Cell Physiol. 2002 Jan;282(1):C172-82.

17.

Mucin gene expression in intestinal epithelial cells in Crohn's disease.

Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP.

Gut. 2001 Oct;49(4):544-51.

18.

Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum.

Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, Geiger H, Obermüller N.

Scand J Gastroenterol. 2002 Nov;37(11):1286-95.

PMID:
12465727
19.

Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease.

Lawrance IC, Maxwell L, Doe W.

Inflamm Bowel Dis. 2001 Aug;7(3):226-36.

PMID:
11515849

Supplemental Content

Support Center